Advanced Biomed Inc Increase (Decrease) in Prepaid Expense and Other Assets
Advanced Biomed Inc (ADVB) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$851.25 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-05-15
- Advanced Biomed Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$199.24K, a 109.73% decline year-over-year.
- Advanced Biomed Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$710.97K.
- Advanced Biomed Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $58.96K, a 38.38% increase year-over-year.
- Advanced Biomed Inc increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was $638.85K, a 4465.20% increase year-over-year.
- Advanced Biomed Inc increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.69M, a 861.09% increase from fiscal 2024.
- Advanced Biomed Inc increase (decrease) in prepaid expense and other assets for fiscal 2024 was $279.43K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | -$199.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$910.21K derived: sum of 2 quarters · filed 2026-05-15 | -$851.25K 10-Q · filed 2026-05-15 | -$212.40K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-12-31 | -$710.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$652.01K 10-Q · filed 2026-02-13 | -$13.16K derived: sum of 3 quarters · filed 2026-02-13 | $2.04M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-09-30 | $58.96K 10-Q · filed 2025-11-19 | $697.81K derived: sum of 2 quarters · filed 2025-11-19 | $2.75M derived: sum of 3 quarters · filed 2026-05-15 | $2.70M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2025-06-30 | $638.85K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $2.69M derived: sum of 2 quarters · filed 2026-05-15 | $2.64M derived: sum of 3 quarters · filed 2026-05-15 | $2.69M 10-K · filed 2025-10-08 | ||
| 2025-03-31 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $2.00M derived: sum of 2 quarters · filed 2026-05-15 | $2.05M 10-Q · filed 2026-05-15 | $2.10M 10-Q · filed 2025-05-15 | $2.06M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$44.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$1.70K 10-Q · filed 2026-02-13 | $38.52K 10-Q · filed 2025-04-15 | $12.29K derived: sum of 3 quarters · filed 2026-02-13 | $22.68K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $42.61K 10-Q · filed 2025-11-19 | $56.60K derived: sum of 2 quarters · filed 2025-11-19 | $66.99K derived: sum of 3 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $13.99K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $24.38K derived: sum of 2 quarters · filed 2025-10-08 | $279.43K 10-K · filed 2025-10-08 | |||
| 2024-03-31 | $10.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $265.43K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $255.05K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |